| Title | Author(s) | Year | View Count |
 | T lymphocyte function in patients with malignant biliary obstruction | Fan, ST; Lo, CM; Lai, ECS; Yu, WC; Wong, J | 1994 | 78 |
 | TACE (Invited Lecture) | Fan, ST | 2000 | 90 |
| Tacrolimus (FK 506)-induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: Salvage with plasmapheresis and prostacyclin | Au, WY; Lie, AKW; Lam, CCK; Fan, ST; Liu, CL; Young, K; Lo, CM | 2000 | 37 |
| Tacrolimus (FK506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin | Au, WY; Lie, AKW; Lam, CCK; Fan, ST; Liu, CL; Young, K; Lo, CM | 2000 | 90 |
| Tacrolimus (FK506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin (abstract) | Au, WY; Lie, AKW; Lam, CCK; Fan, ST; Liu, CL; Young, KK; Lo, CM | 1999 | 106 |
| Tailoring donor hepatectomy per segment 4 venous drainage in right lobe live donor liver transplantation | Chan, SC; Lo, CM; Liu, CL; Wong, Y; Fan, ST; Wong, J | 2004 | 125 |
| Takayasu arteritis - A case report of aortic aneurysm | Lau, H; Cheng, SWK | 1998 | 53 |
| Targeted therapy in the management of advanced gastric cancer: Are we making progress in the Era of personalized medicine? | Wong, H; Yau, T | 2012 | 69 |
| Targeting both acute and chronic rejection: a regimen that ensures hundred percent permanent survival of orthotopic small bowel allograft in rat | Tian, L; Li, X; Tam, PKH | 2003 | 100 |
| Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma | Liu, LX; Lee, NP; Chan, VW; Xue, W; Zender, L; Zhang, C; Mao, M; Dai, H; Wang, XL; Xu, MZ; Lee, TK; Ng, IO; Chen, Y; Kung, HF; Lowe, SW; Poon, RTP; Wang, JH; Luk, JM | 2009 | 368 |
| Targeting cadherin-17 inactivates wnt signaling and inhibits tumor growth in liver carcinoma (Hepatology (2009) 50, DOI: 10.1002/hep.23143) | Luk, JM | 2010 | 32 |
| Targeting cancer stem cells enhances therapeutic efficacy of chemotherapy in hepatocellular carcinoma (Poster Presentation) | Ho, DWY; Yang, Z; Ng, NP; Lau, CK; Poon, RTP; Fan, ST | 2008 | 87 |
| Targeting glycyrrhetinic acid to hepatic stellate cells in treating rat liver fibrosis | Zhang, QS; Luk, JM; Zhang, J; Tian, GY | 2005 | 107 |
| Targeting granulin-epithelin precursor in breast cancer | Ip, YC; Chan, YK; Wong, SY; Cheung, ST; Khoo, US | 2009 | 107 |
 | Targeting mTOR as a novel therapeutic strategy for hepatocellular carcinoma | Tam, Ka-ho, Chris; 譚家豪 | 2006 | 235 |
| Targeting of interleukin-10 is superior to cytotoxic T-lymphocyte associated antigen 4 with human immunoglobulin G 1 for the prevention of chronic allograft deterioration in organ transplantation | Xu, T; Haering, C; Lau, CK; Obed, A; Ma, J; Doenecke, A; Scherer, MN; Schnitzbauer, AA; Fan, ST; Schlitt, HJ; Tsui, TY | 2008 | 148 |
| Targeting of mortalin-mutant p53 interactions by mortalin shRNA leads to selective apoptotic death of human hepatocellular carcinoma (Poster & Abstract) | Lu, WJ; Lee, NPY; Kaul, SC; Poon, RTP; Wadhwa, R; Luk, JMC | 2010 | 83 |
| Targeting of mortalin-mutant p53 interactions by mortalin shRNA leads to selective apoptotic death of human hepatocellular carcinoma (Poster & Abstract) | Lu, WJ; Lee, NPY; Kaul, SC; Poon, RTP; Wadhwa, R; Luk, JMC | 2010 | 92 |
| Targeting serine peptidase inhibitor, Kazal type 1 (SPINK1) as a potential treatment for hepatocellular carcinoma (Abstract) | Shek, HP; Luk, JMC; Lee, NPY | 2011 | 64 |
| Targeting YAP and Hippo signaling pathway in liver cancer | Liu, AM; Xu, MZ; Chen, J; Poon, RT; Luk, JM | 2010 | 461 |
|
